Poster
# 67

Main Page

6th Internet World Congress for Biomedical Sciences

IndexIndex
One-page version
Dynamic pages

GENTAMICIN CONTAINING SURGICAL BONE CEMENT: IN VITRO ELUTION CHARACTERISTICS OF PALACOS® AND PALAMED®

Nina M. van Sorge(1), JP Yska(2), Hans Blansjaar(3), Sandra Driessen(4), Patricia Schepers(5), Simon R. Bovenga(6), A.A. van Sorge(7)
(1)(2)(3)(4)(5)(6)Rijnstate Hospital - ARNHEM. Netherlands
(7)Rijnstate Hospital Arnhem - ARNHEM. Netherlands

[ABSTRACT] [INTRODUCTION] [MATERIALS AND METHODS] [RESULTS] [FIGURES] [DISCUSSION] [CONCLUSION] [BIBLIOGRAPHY] [PRESENTATION FILE] [Discussion Board]
MATERIALS AND METHODS Previous:  Determination of the Protection  Level for Post Chemotherapy Emesis with
a Multilayer Perceptron. 
Previous: A low cost stereo vision system for vertebral column measures FIGURES
[Pharmacology]
Next: Augmentation of antidepressant therapy with 5-HT autoreceptor antagonists: receptor autoradiographic studies of pindolol
[Orthopedics & Traumatology]
Next: ESTERNUM OSTEOMIELITYS: RIB ALLOGRAFT AND HEMITURNOVER AND ADVANCEMENT PECTORALIS MAJOR FLAPS

RESULTS

Results of gentamicin release from both Palacos® and Palamed® using the USP XXIV flow-through cell apparatus are presented in Table 1 and Fig.3.

Table 1
DYNAMIC ELUTION OF GENTAMICIN LOADED SURGICAL CEMENT DURING 190 MIN.

Specialties n Peak gentamicin level (mg/L); at 10 minutesMean gentamicin concentration from 100 minutes (mg/L) Percentage released
Palamed® 4 93,9 ± 16,2 5,73 ± 0,38 27,1
Palacos® 5 32,0 ± 10,7 1,78 ± 0,05 8,8

Fig.3

In the non-dynamic setting leaching of gentamicin from the bone cement was measured. Results of begin and end points are shown in table 2, whereas leaching characteristics of gentamicin during the whole time period are presented in fig.4.

Table 2
NON-DYNAMIC LEACHING OF GENTAMICIN LOADED SURGICAL CEMENT
Specialties Gentamicin level after 3 days
(mg/L)
Gentamicin level after 190 days
(mg/L)
Percentage released after
190 days
Palamed® 1,67 ± 0,13 3,69 ± 0,25 69,9
Palacos® 0,64 ± 0,07 0.67 ± 0,06 13,3


Discussion Board
Discussion Board

Any Comment to this presentation?

[ABSTRACT] [INTRODUCTION] [MATERIALS AND METHODS] [RESULTS] [FIGURES] [DISCUSSION] [CONCLUSION] [BIBLIOGRAPHY] [PRESENTATION FILE] [Discussion Board]

MATERIALS AND METHODS Previous:  Determination of the Protection  Level for Post Chemotherapy Emesis with
a Multilayer Perceptron. 
Previous: A low cost stereo vision system for vertebral column measures FIGURES
[Pharmacology]
Next: Augmentation of antidepressant therapy with 5-HT autoreceptor antagonists: receptor autoradiographic studies of pindolol
[Orthopedics & Traumatology]
Next: ESTERNUM OSTEOMIELITYS: RIB ALLOGRAFT AND HEMITURNOVER AND ADVANCEMENT PECTORALIS MAJOR FLAPS
Nina M. van Sorge, JP Yska, Hans Blansjaar, Sandra Driessen, Patricia Schepers, Simon R. Bovenga, A.A. van Sorge
Copyright © 1999-2000. All rights reserved.
Last update: 11/01/00